Company: SMNR
Filing Date: 2025-10-21
Form Type: S-1
Source: 0001193125-25-245178
Chunk: 428

Company: Semnur Pharmaceuticals, Inc.
Filing Date: 2025-10-21
Form: S-1
Chunk 428
---
, or group, in deciding how to allocate resources and assess performance. The Company has adopted the guidance in ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures, in the accompanying financial statements using the retrospective method of adoption. The Company’s chief operating decision maker has been identified as the Chief Executive Officer (“CODM”), who reviews the operating results for the Company as a whole to make decisions about allocating F-62

resources and assessing financial performance. Accordingly, management has determined that the Company only has one operating and reportable segment.

When evaluating the Company’s performance and making key decisions regarding resource allocation the CODM reviews several key metrics, which include the following:

|                                                                   |     | Three monthsEnded June 30,2025 |          |   |     | Three monthsended June 30,2024 |          |   |     | Six monthsended June 30,2025 |          |   |     | Six monthsended June 30,2024 |           |   |
|:------------------------------------------------------------------|:----|:-------------------------------|---------:|:--|:----|:-------------------------------|---------:|:--|:----|:-----------------------------|---------:|:--|:----|:-----------------------------|----------:|:--|
| Professional Services fee in connection with Business Combination |     | $                              | (313,643 | ) |     | $                              |  (59,345 | ) |     | $                            | (428,550 | ) |     | $                            |  (278,673 | ) |
| Other formation and operating costs                               |     |                                |  (61,214 | ) |     |                                | (108,841 | ) |     |                              | (192,907 | ) |     |                              |  (257,765 | ) |
| Total formation and operating costs                               |     |                                | (374,857 | ) |     |                                | (168,186 | ) |     |                              | (621,457 | ) |     |                              |  (536,438 | ) |
| Interest expense                                                  |     |                                |  (28,345 | ) |     |                                |  (23,059 | ) |     |                              |  (55,319 | ) |     |                              |   (44,362 | ) |
| Interest earned on investment held in Trust Account               |     |                                |   18,080 |   |